MXCT – maxcyte, inc. (US:NASDAQ)

News

Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO [Yahoo! Finance]
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO
MaxCyte (NASDAQ:MXCT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
MaxCyte (NASDAQ:MXCT) was upgraded by analysts at Wall Street Zen fr
MaxCyte (NASDAQ:MXCT) was upgraded by analysts at Wall Street Zen fr
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com